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Background: There is still an urgent clinical need to develop non-invasive diagnostic
tests for early ischemic heart disease because, once angina occurs, it is too late.
Hypocapnia has long been known to cause coronary artery vasoconstriction. Some new
cardiology tests are accompanied by the claim that they must have potential diagnostic
value if hypocapnia enhances their cardiac effects in healthy subjects. But no previous
study has tested whether hypocapnia produces bigger cardiac effects in patients with
angina than in healthy subjects.
Methods: Severe hypocapnia (a PetCO2 level of 20 mmHg) lasting >15 min was
mechanically induced by facemask, while conscious and unmedicated, in 18 healthy
subjects and in 10 patients with angina and angiographically confirmed coronary
artery disease, awaiting by-pass surgery. Each participant was their own control in
normocapnia (where CO2 was added to the inspirate) and the order of normocapnia
and hypocapnia was randomized. Twelve lead electrocardiograms (ECG) were recorded
and automated measurements were made on all ECG waveforms averaged over
>120 beats. 2D echocardiography was also performed on healthy subjects.
Results: In the 18 healthy subjects, we confirm that severe hypocapnia (a mean
PetCO2 of 20 ± 0 mmHg, P < 0.0001) consistently increased the mean T wave
amplitude in leads V1–V3, but by only 31% (P < 0.01), 15% (P < 0.001) and 11%
(P < 0.05), respectively. Hypocapnia produced no other significant effects (p > 0.05)
on their electro- or echocardiogram. All 10 angina patients tolerated the mechanical
hyperventilation well, with minimal discomfort. Hypocpania caused a similar increase in
V1 (by 39%, P < 0.05 vs. baseline, but P > 0.05 vs. healthy controls) and did not induce
angina. Its effects were no greater in patients who did not take β-blockers, or did not
take organic nitrates, or had the worst Canadian Cardiovascular Society scores.
Frontiers in Physiology | www.frontiersin.org 1 January 2020 | Volume 10 | Article 1515
fphys-10-01515 December 16, 2019 Time: 19:0 # 2
Parkes et al. Hypocapnia on the ECG in Angina
Conclusion: Non-invasive mechanical hyperventilation while awake and unmedicated
is safe and acceptable, even to patients with angina. Using it to produce severe and
prolonged hypocapnia alone does produce significant ECG changes in angina patients.
But its potential diagnostic value for identifying patients with coronary stenosis requires
further evaluation.
Keywords: hypocapnia, coronary artery vasoconstriction, electrocardiogram, angina, mechanical
hyperventilation, calcium
INTRODUCTION
In patients with angiographically confirmed coronary artery
disease, voluntary hyperventilation-induced hypocapnia to
∼20 mmHg causes some coronary artery constriction (Rowe
et al., 1962; Neill and Hattenhauer, 1975). In healthy subjects,
voluntary hyperventilation is also variously reported to cause
ECG changes (Rutherford et al., 2005) and to enhance the
effects of non-invasive techniques that may assess myocardial
oxygenation (Guensch et al., 2013). Furthermore there is a
greater fall in their myocardial OS-CMR signal (−11%) with
voluntary hyperventilation than the rise in this signal (+4%)
with adenosine (Fischer et al., 2014). Assessing coronary vascular
function using voluntary hyperventilation-induced hypocapnia
as an endogenous vasoconstrictor is also suggested as a clinically
exciting prospect because it is safe, non-invasive and presumably
free of the side effects of pharmacological effects in combination
with contrast agents (Guensch et al., 2013; Fischer et al., 2014).
But the benchmark is whether hypocapnia produces bigger
effects in patients with myocardial ischemia. To our knowledge
this has not previously been studied (Rutherford et al., 2005;
Fischer et al., 2014; Crystal, 2015).
Voluntary hyperventilation is difficult for both healthy
subjects and patients and produces short periods (a few minutes)
of unstable hypocapnia (Rutherford et al., 2005). Non-invasive
mechanical hyperventilation by facemask is a superior technique
for inducing long and stable periods of severe hypocapnia.
We have already established that this is easy for conscious,
unmedicated and healthy subjects, and for patients with breast
cancer (Parkes et al., 2016b), and produces long periods (up to
1 hr) of stable hypocapnia as severe as can safely be applied
to patients (Cooper et al., 2003, 2004; Rutherford et al., 2005;
Sheppard et al., 2011; Parkes et al., 2019). Since mechanically
induced hypocapnia is so simple, cheap and comfortable (for
patients) to perform, it is potentially viable as a diagnostic
modality for identifying patients with fixed coronary stenoses.
Furthermore, non-invasive mechanical ventilation is now being
considered to assist radiotherapy, both for cardiac ablation and
for radiotherapy delivery to reduce respiratory motion of thoracic
and abdominal cancers (Parkes et al., 2016b; West et al., 2018; Van
Ooteghem et al., 2019). There is therefore a need to demonstrate
whether it would be well tolerated in patients with co-morbid
coronary artery disease.
Here we test for the first time whether angina patients can
be mechanically hyperventilated non-invasively. This technique
can induce more severe and prolonged hypocapnia than can
be induced by voluntary hyperventilation. We therefore tested
whether this hypocapnia induces ECG and echocardiographic
changes in healthy controls and in patients with angina due
to demonstrated coronary artery disease. In this small proof
of concept study, we also evaluated whether these changes
were greater in patients with coronary artery disease than in
healthy controls.
MATERIALS AND METHODS
Experiments were conducted in the NIHR/WTCRF at the
University Hospital Birmingham. All participants gave informed
consent and all experiments were approved by the Walsall Local
Research Ethics Committee and were performed in accordance
with the Declaration of Helsinki and Good Clinical Practice. As
an additional safety precaution, experiments on angina patients
were conducted in the presence of a currently trained intensive
care unit nurse.
We tested 18 normal healthy subjects (aged 20–30 years, 13
males) with no known cardiovascular disease and who were not
smokers. We also tested 10 male patients aged 43–72 years with
history of typical angina pectoris and angiographically confirmed
severe coronary heart disease who were awaiting bypass surgery.
Patients had stable exertional angina without rest pain or ECG
abnormalities. 5/10 had triple vessel disease and all clinical details
and medications are given in Table 1. Patients taking prophylactic
long acting nitrates had these discontinued 36 h in advance and
none had taken short acting nitrates for 2 h prior to testing.
Blood pressure was recorded continuously using a finger
plethysmograph (Finapres 2300) and end tidal partial pressure
of carbon dioxide (PetCO2) via an in-line capnograph (Hewlett
Packard 78354A). All data were recorded by a CED1401
(Cambridge Electronic Design). Antecubital venous catheters
were inserted in 14 of the healthy subjects. Because hypocapnia
is often believed to cause electrolyte changes (Rutherford et al.,
2005), one 10 ml sample was taken at the end of the normocapnia
and hypocapnia periods and ionized Ca2+ and K+ levels were
measured using a blood gas analyzer (Rapid Lab 865).
In the 18 healthy subjects, echocardiographic recordings were
also performed as an independent measure of any potentially
ischemic changes in heart function during hypocapnia. 2D
echocardiography was used to assess wall motion, Doppler
flow analysis was used to measure diastolic function and tissue
Doppler analysis was used to measure myocardial wall velocity.
All participants were conscious and unsedated, without
previous experience of non-invasive mechanical hyperventilation
by facemask. All were positioned semi-recumbent. Mechanical
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TABLE 1 | Patient details and medication.
Patient Age BMI Hyper-tension Diabetic Ventricular function Low dose aspirin NYAA CCS Iso-sorbide βblocker Nicorandil ACE inhibitor
1 54 26 No No Good Yes 1 2 Yes
2 72 26 Yes No Good Yes 2 2 Yes Yes Yes
3 43 22 No No Good Yes n/a n/a Yes
4 75 31 No No Half Yes 2 2 Yes
5 65 32 Yes No Good 2 2 Yes Yes Yes
6 68 23 Yes No Good Yes 2 2 Yes Yes Yes
7 57 28 Yes Yes Good Yes 2 3 Yes Yes Yes Yes
8 52 31 No No Good Yes 2 3 Yes Yes
9 64 32 Yes No Good Yes 1 3 Yes Yes
10 57 36 yes Yes Good Yes 2 3 Yes Yes
Vessel disease >50% stenosis with corresponding leads where ECG changes might be expected
Patient Stent Previous MI. R/L dominant Vessel V1-V4 V4-V6 aVF, II, and III
1 Yes Yes Right Triple Prox LAD Circumflex R coronary block
2 Right Triple Prox LAD Prox circumflex R coronary
3 Right Single Prox LAD – –
4 Right Double LAD block Prox circumflex –
5 Right Double Prox LAD Circumflex (OMI) –
6 Left Triple Prox LAD Circumflex –
7 Left Triple LAD block Prox circumflex(distal blocked) –
8 Right Triple Prox LAD Circumflex R coronary
9 Left Single Prox LAD – –
10 Yes Yes n/a Double Prox LAD Prox circumflex (Inferior MI.)
n/a, not available.
hyperventilation by facemask in air was performed
(Cooper et al., 2003, 2004; Rutherford et al., 2005; Parkes
et al., 2014) at 16 breaths per minute and with an inflation
volume increased to induce a PetCO2 level of 20 mmHg. All
had 1–2 practice sessions in which all experimental maneuvers
were performed on previous days. Each participant was their
own control and, for the control (normocapnia) condition, we
applied the same inflation frequency and inflation volume but
added sufficient flow of 5% CO2 in air to restore their PetCO2
to their own eupneic levels. All had two sessions of mechanical
hyperventilation on separate days where normocapnia and
hypocapnia were established for at least 15 min, and applied in
random order, before making the 2-min recordings. Therefore,
only if changes were consistently reproducible in all experiments,
over multiple subjects and repeatable on two separate days would
they be statistically significant.
Twelve lead ECG waveforms were calculated using standard
formulae (Wagner, 2008; Sheppard et al., 2011). Signal averaging
techniques (Rutherford et al., 2005) were used to maximize
sensitivity in detecting any consistently reproducible ECG
changes, with averaging performed “blind” using fully automated
algorithms for 2 min periods (∼120 beats) to derive ECG
amplitude in mV [P, Q, R, ST segment (S, J slope, J, J80 height),
RS and T heights] and timing in seconds (QT, QTc, PR, and
QRS intervals, Q and T duration). We then calculated the mean
measurement for the two normocapnia and hypocapnia sessions
for each subject. Measurements were also validated (Sheppard
et al., 2011) with an electronic ECG simulator (Dynatech
Nevada Inc., Model 212B, Nevada) and against a Philips Hewlett
Packard Pagewriter 200. Our analysis has the sensitivity to detect
ECG changes two orders of magnitude lower that the clinical
thresholds of 0.1 mV.
Since ECG amplitude decreases as inflation volume increases
(Rutherford et al., 2005), clinical thresholds depend on the
inflation volume used. To adjust these thresholds for the
hyperventilation inflation volume we used, in each lead we
measured the percentage change in T wave amplitude in healthy
subjects between eupnea and the volume at which each was
hyperventilated and adjusted each clinical threshold accordingly
(see Table 2). Recent guidelines also recommend consideration of
gender differences in the ventricular repolarization phase of the
cardiac cycle (Surawicz and Parikka, 2002) for leads exhibiting
the largest T wave and ST segments i.e., transverse plane leads
(Wagner et al., 2009). So we also took gender into account.
Table 2 shows the absolute thresholds (mV) and our adjusted
thresholds indicating clinical significance for the ECG measured
in eupnea from the American Heart Association (AHA),
American College of Cardiology Foundation (ACCF) and Heart
Rhythm Society (HRS) (Wagner, 2008; Surawicz et al., 2009;
Wagner et al., 2009).
Statistical analysis used a two tailed paired t-test with p< 0.05
taken as significant, with each participant’s measurements
in normocapnia paired with their own measurements in
hypocapnia. We have not applied the Bonferroni correction for
ECG statistical analysis because we cannot assume all 12 ECG
leads are independent and uncorrelated, so this correction is too
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TABLE 2 | clinical threshold changes for eupnea and hyperventilation.
Lead AHA clinical threshold AHA clinical threshold change
change in eupnea adjusted for hyperventilation
I >1.0 mV >0.4 mV
II >1.0 mV >0.5 mV
III >1.0 mV >0.8 mV
aVR >1.0 mV >0.4 mV
aVL >1.0 mV >0.3 mV
aVF >1.0 mV >0.5 mV
V1 >1.0 mV >2.1 mV
V2 >1.0 mV >1.0 mV
V3 >1.0 mV >1.0 mV
V4 >1.0 mV >0.9 mV
V5 >1.0 mV >1.2 mV
V6 >1.0 mV >0.9 mV
FIGURE 1 | Effect of hypocapnia on the T wave in healthy subjects.
Mean ± SE T wave amplitude in 18 healthy subjects during normocapnia or
hypocapnia. ∗P < 0.05, ∗∗p < 0.01, paired t-test.
conservative. Comparison between healthy subjects and patients
used an unpaired t-test. All data presented is expressed as mean
±standard error. Statistical review of this study was performed by
a biomedical statistician.
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RESULTS
Hypocapnia in 18 Healthy Subjects
It took only a few minutes to accustom healthy subjects to
mechanical hyperventilation. This caused significant decreases
in PetCO2 (falling by 18 mmHg, from 38 ± 0 mmHg to
20 ± 0 mmHg, P < 0.0001), in mean arterial pressure (by
9 ± 3 mmHg, from 94 ± 4 mmHg, P < 0.01) and a trivial
decrease in calcium levels (by only 0.03 ± 0.01 mmol/l from
1.2 ± 0.0 mmol/l, P < 0.001). It significantly increased mean
heart rate (by 4 ± 1 b.p.m. from 58 ± 2 b.p.m., P < 0.01)
and had no significant effects on plasma potassium levels
(4.0± 0.1 mmol/l).
Figure 1 shows that for limb leads, hypocapnia caused no
significant T wave changes. For chest leads it caused a significant
change only in leads V1–V3 (mean elevations, respectively of 31%
i.e., 0.06 ± 0.01 mV, P < 0.01; of 15% i.e., 0.09 ± 0.02 mV,
P < 0.001; and of 11%, i.e., 0.07 ± 0.02 mV, P < 0.05). All
changes remained within clinically acceptable limits for normal
T wave amplitude changes (Table 2). Significant T wave elevation
occurred in males in leads V1−3, but only in V1 in females. T wave
elevation during hypocapnia was not accompanied by consistent
changes of any of the 12 ECG leads in the ST segment nor other
amplitudes (P, Q, R, RS heights) or timings (QT, QTc, PR, QRS
intervals, Q or T durations).
Echocardiography was feasible and straightforward during
mechanical hyperventilation. But in our healthy subjects it was
even less sensitive than electrocardiography in that it failed
to detect any significant effects of hypocapnia on wall motion
or diastolic function i.e., no significant effects nor changes
beyond clinically normal values on wall motion [LVID difference,
−1.80± 0.0 cm [normocapnia] vs.−1.81± 0.0 cm (hypocapnia),
P > 0.90; fractional shortening, 36 ± 1% (normocapnia) vs.
34 ± 2% (hypocapnia), P > 0.10], diastolic function [E/A
ratio, 1.99 ± 0.13 [normocapnia] vs. 1.78 ± 0.14 (hypocapnia),
P > 0.10; deceleration time 0.20 ± 0.01 s (normocapnia) vs.
0.21 ± 0.01 s (hypocapnia), P > 0.45] nor on diastolic wall
velocities in both the septum [12.6 ± 0.5 cm/s (normocapnia)
vs. 12.4 ± 0.3 cm/s (hypocapnia), P > 0.60] and lateral wall
[16.7± 0.6 cm/s (normocapnia) vs. 16.4± 0.5 cm/s (hypocapnia),
P > 0.60]. For this reason, echocardiography was not pursued in
our angina patients.
Hypocapnia in 10 Angina Patients
Mechanical hyperventilation (lasting up to∼1 h) and hypocapnia
were as safe and easy to accustom and apply in angina patients
as in healthy subjects. During mechanical hyperventilation,
none could distinguish between normocapnia and hypocapnia
(Cooper et al., 2004; Rutherford et al., 2005) and none reported
any distress or particular discomfort. More importantly, none
experienced angina. Mechanical hyperventilation caused mean
PetCO2 levels to decrease (from 38± 0 mmHg to 20± 0 mmHg,
P < 0.0001) with no significant effects on mean heart rate
(61 ± 9 b.p.m.) nor in mean arterial pressure (92 ± 6 mmHg).
Again, none experienced angina.
Based on the location of the site of their coronary stenoses,
we expected hypocapnia induced coronary artery constriction to
produce more pronounced T wave changes for all 10 patients in
V1–V4, for 8/10 patients in V4–V6 and for 4/10 in II, III, and
aVF. No such pronounced changes were found.
Figure 2 shows that hypocapnia did cause significant
ECG changes in angina patients, but these changes were not
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FIGURE 2 | Effect of hypocapnia on the T wave in angina patients.
Mean ± SE T wave amplitude in 10 angina patients during normocapnia or
hypocapnia. ∗P < 0.05, paired t-test.
significantly greater than those observed in healthy subjects
(P > 0.05 by unpaired t-test) and ST depression (the usual
hallmark of subendocardial ischemia) was not observed. Thus
hypocapnia caused significant changes in only lead V1 T wave
(a 39% elevation, by 0.035 ± 0.014 mV, p < 0.05), but no other
measurable nor consistent ECG change in either amplitude (P, Q,
R, RS, ST segment heights) nor in timing (QT l, QTc, PR, QRS
intervals, Q, T durations).
Performing the same analysis above on only the 5 patients
with triple vessel disease showed no greater or more consistent
effects of hypocapnia on ECG amplitude or timing. Similarly,
inspection of individual results revealed no obviously greater
effects in patients who never took β blockers (#3, #4) or never
took organic nitrates (#1, #4, #10) or in those with the worst
Canadian Cardiovascular Society scores (#7, #8, #9, #10).
DISCUSSION
Since the 1930s, clinical and often anecdotal reports
have suggested that voluntary hyperventilation-induced
hypocapnia might affect the electrocardiogram (McCance,
1932). Surprisingly ours is the first systematic test of whether
hypocapnia produces effects in patients with angina that are
any greater than those observed in healthy subjects. Despite
our producing more consistent and severe hypocapnia, in
more patients, in more consistently ill patients (all with
angiographically confirmed coronary heart disease, exertional
angina and awaiting bypass surgery) and for longer durations
than any previous studies (McCance, 1932; Rowe et al., 1962;
Neill and Hattenhauer, 1975; Freeman and Nixon, 1985;
Kruyswijk et al., 1986; Rutherford et al., 2005; Guensch et al.,
2013; Fischer et al., 2014), we found that ECG changes were no
more marked in patients with angina than in healthy controls.
The most severe hypocapnia that can safely be achieved
in humans during hyperventilation with air (without causing
tetany) is an arterial partial pressure of carbon dioxide (PaCO2)
of 20 mmHg (Rutherford et al., 2005). This causes severe
constriction of epicardial resistance vessels (Rowe et al., 1962;
Neill and Hattenhauer, 1975) and reduces coronary blood flow
by up to 30% (Rowe et al., 1962; Neill and Hattenhauer, 1975;
Yokoyama et al., 2008; Crystal, 2015). The reduced coronary
blood flow, possibly coupled with the increased the affinity of
hemoglobin for O2 (Neill and Hattenhauer, 1975), is thought to
have the capability of reducing oxygen supply to the myocardium
(Guensch et al., 2013; Fischer et al., 2014; Crystal, 2015). This is
despite the fact that classic respiratory physiology (according to
the alveolar gas equation) demonstrates that lowering PaCO2 by
20 mmHg must also raise alveolar PO2 by and equal 20 mmHg.
Such voluntarily-induced hypocapnia does provoke angina very
occasionally in some patients with stable coronary artery disease
(Rowe et al., 1962; Neill and Hattenhauer, 1975; Crystal, 2015).
It also provokes a characteristic focal epicardial coronary artery
spasm with coronary occlusion in the very small number of
patients suffering from Prinzmetal’s angina (Pepine et al., 1992)
and has been used as a diagnostic test for Prinzmetal’s angina.
But to develop a diagnostic test that consistently reveals
in every patient with early coronary artery disease any
haemodynamically significant coronary plaque, and or provokes
coronary artery spasm, the key question is whether hypocapnia
produces greater effects in patients with established ischemic
heart disease than in healthy volunteers. We undertook our study
since the potential diagnostic utility of hyperventilation induced
hypocapnia to identify patients with fixed coronary artery
stenosis has not been investigated previously. This is despite
almost every new non-invasive test being claimed as potentially
important if hypocapnia enhances its results in healthy subjects.
Even in healthy subjects, it has never been satisfactorily
established whether hypocapnia does consistently affect the ECG,
because previously voluntary hyperventilation was always used.
The reliability and reproducibility of voluntary hyperventilation
is questionable (Rutherford et al., 2005). This is because
of its limitations in inducing sufficiently stable, severe, and
reproducible hypocapnia and the additional pressor changes and
ECG movement artifacts from the large variations in voluntary
chest inflation. Thus it only caused ischemic changes in the T
wave, ST segment and QTc interval in 8–57% of healthy subjects
(McCance, 1932; Christensen, 1946; Wasserburger et al., 1956;
Golden et al., 1975; Joy and Trump, 1981) and does not even
always affect angina patients (Kenigsberg et al., 2007).
We previously developed a method (Rutherford et al.,
2005) in healthy volunteers to induce prolonged hypocapnia
by using mechanical hyperventilation with a facemask. This
is easily tolerated in conscious and unmedicated subjects and
provides an entirely uniform pattern of lung inflation and
more severe, prolonged and stable hypocapnia at 20 mmHg
without any consistent pressor or electrolyte changes. Indeed
such non-invasive mechanical hyperventilation has widespread
clinical application e.g., for radiotherapy to assist cardiac
ablation and to reduce movement during all radiotherapy
in the thorax and abdomen (Parkes et al., 2016a,b; West
et al., 2018; Van Ooteghem et al., 2019). But there is still
little clinical awareness of the simplicity, availability, and
safety of this technique. We also developed a method to
standardize ECG waveform measurement, by averaging it
over ∼120 heart beats (Rutherford et al., 2005), so that
Frontiers in Physiology | www.frontiersin.org 5 January 2020 | Volume 10 | Article 1515
fphys-10-01515 December 16, 2019 Time: 19:0 # 6
Parkes et al. Hypocapnia on the ECG in Angina
only consistently reproducible effects would be found.
Whereas previous ECG analysis techniques tended to select
only the occasional and discrepant ECG waveforms. With
our techniques we found that hypocapnia significantly
decreased T wave amplitude in a modified lead I in 13/15
healthy subjects by a mean of 0.1 mV (Rutherford et al.,
2005). Furthermore, we recently validated a highly sensitive
and fully automated averaging system for 12 lead ECG
measurement to perform this analysis on patients and specified
precisely what filtering and other waveform manipulation was
applied (Sheppard et al., 2011). Our new automated system
was applied here.
Hypocapnia in Healthy Subjects
Previously for healthy subjects (Rutherford et al., 2005) we
used a modified three lead ECG using an analog amplifier
and analyzed data manually. Here we used digital amplifiers
and our “blind”, more sophisticated and rigorous calibration
and analysis (Sheppard et al., 2011), with changes compared
to the latest clinical thresholds (Table 2) set out by the AHA,
ACCF, HRS (Wagner, 2008; Rautaharju et al., 2009; Surawicz
et al., 2009; Wagner et al., 2009). Here the incidence of T
wave changes with hypocapnia (in 61% of subjects in lead
I) is less than the 87% we found previously in our group
of different healthy subjects (Rutherford et al., 2005) and the
amplitude change is smaller too. Nevertheless we confirm here
that mechanically induced hypocapnia in a new set of healthy
subjects still produces consistent T wave effects (increases of
up to 31%, 0.06–0.09 mV in leads V1−3). It is possible that
these ECG changes do reflect some vasoconstriction caused by
hypocapnia. These ECG effects, however, are small, are below
the current AHA clinical thresholds and were not accompanied
by any significant changes in any other features of the 12
lead ECG. Neither could we detect hypocapnia causing any
impairment in cardiac function using echocardiography in
healthy subjects.
This small effect on the T wave is not caused by changes
in plasma electrolytes, because we confirm previous results
(Rutherford et al., 2005) that such mechanical hyperventilation
has negligible effects on electrolyte levels. The only significant
electrolyte difference we found was in Ca2+ levels (a significant
fall in hypocapnia of only 0.03 mM). This fall is so trivial
(ionized Ca2+ levels still remained within the normal range
of 1.1–1.4 mM) that it is too small to affect T wave height.
Moreover we found previously (Rutherford et al., 2005)
that hypocapnia produced a bigger T wave effect with no
significant effect on plasma Ca2+ levels (1.23 ± 0.01 mM).
In any event, it is K+, rather than Ca2+ flux, that is
primarily associated with the repolarization phase of the cardiac
action potential.
We also confirm that hypocapnia induced by mechanical
hyperventilation produces negligible changes in heart rate and
blood pressure in healthy subjects (Cooper et al., 2003, 2004;
Rutherford et al., 2005; Parkes et al., 2014) and in patients with
breast cancer (Parkes et al., 2016b).
The methodological advantage of demonstrating that
mechanically induced hypocapnia does consistently produce
significant effects even in healthy subjects is that this offers an in-
built positive result. So the only further requirement is that this
positive effect is bigger in patients with coronary artery disease.
Hypocapnia in Angina Patients
Our patients had typical and debilitating angina with
angiographically confirmed severe epicardial coronary artery
disease (warranting surgical intervention). Hypocapnia to
a mean PetCO2 of 20 ± 0 mmHg did produce statistically
significant changes in the T wave of the ECG in our angina
patients. But in none did it cause angina. It is possible that
these ECG changes reflect some hypocapnia-induced coronary
artery constriction. Further angiography during mechanical
hyperventilation would confirm this. Simultaneous comparison
with the results of stress echocardiography, myocardial-
scintigraphy and stress cardiac MRI in a larger number of
patients would provide definitive comparison of all such
techniques. Nevertheless these effects of hypocapnia on the
ECG are no greater than those in healthy subjects and are well
below the AHA clinical threshold. So a means of enhancing
any coronary vasoconstricting effects of hypocapnia is an
obvious next step.
There are a few case reports of single patients being
admitted because of spontaneous hyperventilation to 15 mmHg
(Kruyswijk et al., 1986) or 12 mmHg (Freeman and Nixon,
1985) and experiencing angina, but such PaCO2 levels would
be considered unsafe to impose on patients for a routine
clinical test. So we do have a positive result that confirms
hypocapnia at 20 mmHg still has effects in angina patients.
But without producing bigger effects on the ECG than in
healthy subjects, or causing angina, hypocapnia alone is not
yet a clinically useful tool. Why hypocapnia has no greater
effects in angina patients is unclear. Possibly hypocapnia only
constricts the resistance vessel less distal to the stenosis (because
of endogenous production of vasodilators), which therefore
reduces the pro-ischemic effect. Or possibly the stenosis itself
subsequently renders the surrounding coronary artery tissue
insensitive to hypocapnia.
Strengths and Limitations
We did not recruit female patients, although we have no evidence
that females might be more responsive to hypocapnia. Similarly,
although our healthy subjects are not age matched with our
patients, this is of little importance. Each subject is their own
control and the older group is if anything less, rather than more
responsive to hypocapnia, so our data is not biased toward a
positive result.
We showed previously in healthy volunteers (Rutherford
et al., 2005) that mechanical hyperventilation is superior to
voluntary hyperventilation in inducing longer and stable periods
of more severe hypocapnia. Mechanical hyperventilation in
conscious and unsedated patients with angina was simple,
safe and straightforward. All 10 patients tolerated it well with
minimal discomfort and all returned on multiple occasions
to complete the study. Some were ventilated for up to 1 h
and none objected to this. Experiments, however, usually
lasted ∼30 min, but could be further shortened if required.
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Our demonstration with angina patients of the safety and
acceptability of mechanical hyperventilation and hypocapnia
is an important milestone in the advocacy of non-invasive
mechanical hyperventilation by facemask.
Implications for the Search for
Non-invasive Tests of Early Coronary
Artery Disease
It is always encouraging for new and non-invasive procedures
where mild hypocapnia (∼30 mmHg), induced by voluntary
hyperventilation, produces myocardial changes detectable in
healthy subjects. But voluntary hyperventilation produces
notoriously variable results in cardiology due the variability
in achieved inflation volumes, duration and stability of
hypocapnia and requires considerable co-operation of the subject
(Rutherford et al., 2005).
Our current and previous results show that even well
conducted studies only on healthy volunteers are not in
themselves clinical validation that such procedures will have
any clinical diagnostic value. We have not tested any of the
more recently described new and non-invasive cardiac diagnostic
techniques ourselves, nor made direct comparisons with known
pharmacological diagnostic procedures. But the overriding result
from our angina patients is that severe and prolonged hypocapnia
alone never itself produced angina. This is even when applying
the more rigorous mechanical hyperventilation to induce more
severe and prolonged hypocapnia (∼20 mmHg). We therefore
establish that even this degree of hypocapnia does not at
present reach the benchmark that such tests should consistently
produce angina and greater ECG and other cardiac changes in
patients with coronary artery disease. Clinicians may therefore
be circumspect in considering any claims for hypocapnia, on its
own, being worth further clinical evaluation without the further
modifications that we now propose below.
There is still a need for low cost, practical and sensitive
diagnostic tests for early coronary artery disease that are
non-invasive and avoid pharmacological interventions (e.g.,
adenosine). Mechanically induced hypocapnia still has potential
because it is so simple, safe, comfortable and easy to apply. One
possible new means of enhancing any coronary vasoconstricting
effects of hypocapnia would be to combine it with a lesser degree
of hypoxia than used in previously described studies. (This would
be instead of the more usually considered asphyxia i.e., hypoxia
with hypercapnia). Early studies using inspiration of hypoxic
gas mixtures (8–12% oxygen) in angina patients did consistently
produce pronounced ST and T wave ECG changes (Levy et al.,
1939, 1941; Turner and Morton, 1952; Haarstad and Broch,
1958; Broch, 1972) and angina (Levy et al., 1939, 1941; Turner
and Morton, 1952; Haarstad and Broch, 1958). Initially this was
considered as a possible diagnostic test for early coronary artery
disease. Its sensitivity and specificity was believed as good or
better than exercise testing (Levy et al., 1941; Turner and Morton,
1952; Stewart and Carr, 1954; Haarstad and Broch, 1958). But
severe hypoxia was abandoned in the 1950s because hypoxia
did induce angina (Levy et al., 1939, 1941; Turner and Morton,
1952; Haarstad and Broch, 1958), patient distress, and had the
potential for adverse risks including myocardial infarction or
death (Stewart and Carr, 1954).
More modern and non-invasive oxygen and heart monitoring
combined with better patient screening may, however, make such
a hypoxia challenge much safer. So, the next approach could
be first to test whether combining hypocapnia with a milder
level of hypoxia that is clinically safe, might produce greater and
easily measurable effects in patients with ischemic heart disease.
If so, this combined hypocapnia-with-hypoxia test could then be
compared for efficacy, safety, and ease of use with the range of
tests for coronary artery disease currently in use. It could then
be tested also how well such positive results predict angina that
develops at a later stage and therefore detects for the first time
clinically silent coronary artery disease.
CONCLUSION
In healthy subjects, hypocapnia has long been known to cause
severe constriction of epicardial resistance vessels, reductions
in coronary artery blood flow, myocardial oxygenation and
small changes in the T wave of the ECG. While it is
increasingly believed that hypocapnia might offer some clinical
benefit as a non-invasive diagnostic tool for early coronary
artery disease, nobody has previously tested whether its effects
are any greater in patients with angiographically established
coronary artery disease.
We show that non-invasive mechanical hyperventilation in
awake and unmedicated patients with angina is acceptable and
safe. We applied more severe hypocapnia and for longer periods
than previously, but we show that the effects of hypocapnia
alone are no greater in patients with angiographically established
coronary artery disease. The goal of developing a simple, safe and
non-invasive test of early coronary artery disease is still being
pursued. What may be done next is to test whether larger and
clinically important effects in patients with ischemic heart disease
occur if such severe hypocapnia is combined with mild hypoxia.
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